Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Do Dieu-Huong has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Asad Murtaza

    Faculty of Biosciences, Fisheries and Economics, Norwegian College of Fishery Science, UiT—The Arctic University of Norway, P.O. Box 6050 Tromsø, Norway

    1 shared publication
  • Haroon Afzal

    International Program in Animal Vaccine Technology, International College, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan

    1 shared publication
  • Li-Ting Cheng

    Graduate Institute of Animal Vaccine Technology, College of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan

    1 shared publication
  • Muhammad Hamza Tariq

    Department of Biomedical Engineering and Biotechnology, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates

    1 shared publication
  • Nguyen-Thanh Hoa

    International Program in Animal Vaccine Technology, National Pingtung University Science and Technology, Pingtung 91201, Taiwan

    1 shared publication
  • Yao-Chi Chung

    Graduate Institute of Animal Vaccine Technology, College of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan

    1 shared publication

Latest Publications

  • Open Access

    Advancing PEDV Vaccination: Comparison between Inactivated and Flagellin N-Terminus-Adjuvanted Subunit Vaccines

    by Asad Murtaza, Nguyen-Thanh Hoa, Do Dieu-Huong, Haroon Afzal, Muhammad Hamza Tariq, Li-Ting Cheng, Yao-Chi Chung

    Vaccinations can serve as an important preventive measure against the porcine epidemic diarrhea (PED) virus that currently threatens the swine industry. This study focuses on the development of a fusion protein vaccine, FliC99-mCOE, which combines the N-terminus of flagellin (FliC99) with a modified core neutralizing epitope (mCOE) of PEDV. In silico immunoinformatic analysis confirmed the construct’s non-toxic, non-allergenic, and highly antigenic nature. Molecular docking and molecular dynamics (MD) simulations demonstrated FliC99-mCOE’s strong binding to the TLR-5 immunological receptor. Repeated exposure simulations and immunological simulations suggested enhanced cell-mediated immunity. Both FliC99-mCOE and an inactivated PEDV vaccine were produced and tested in mice. The results from cell proliferation, ELISA, and neutralization assays indicated that FliC99-mCOE effectively stimulated cellular immunity and neutralized PEDV. We conclude that the FliC99-mCOE fusion protein may serve as a promising vaccine candidate against PEDV.